InflaRx (IFRX) details Phase 3 post-hoc data in PG
InflaRx (Nasdaq: IFRX) provided updated analyses from its terminated Phase 3 study of vilobelimab in…
First multiple sclerosis patient in the UK receives CAR T cell therapy in groundbreaking trial
A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented…
Stroke experts call for ethical guardrails as AI expands in clinical research
As artificial intelligence (AI) use continues to grow in nearly every industry, it is important to establish guardrails…
Elon Musk’s Neuralink brain chip implanted into 2 quadriplegic Canadian patients as part of clincal trial
Two Canadian patients with spinal cord injuries have received Neuralink brain implants that have allowed them to control…
Medical Horizons and Bowhead Health Inc. Announce Exclusive Partnership to Bring AI-Powered Clinical Research Solutions to Italy, Turkey, and Cyprus
FLORENCE, Italy, Sept. 2, 2025 /PRNewswire/ — Medical Horizons S.r.l., (medicalhorizons.it) a leading distributor of Artificial Intelligence (AI)…
“We aim to position Korea among the global top 3 in clinical trial competitiveness and establish it as Asia’s central research hub”
“We aim to position Korea among the global top 3 in clinical trial competitiveness and establish it as…
Iran-Israel conflict disrupts trial initiations
Escalating conflict between Israel, Iran and the US had a marked impact on clinical trial initiations in Q2…
AI Impact Awards 2025: Every Cure Aims to ‘Teach Old Drugs New Tricks’
Every Cure, a nonprofit working to reveal the untapped potential of existing medications, has emerged as the overall…
Tempest Reports Year End 2024 Financial Results and Provides Business Update
Tempest Therapeutics • Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of…
CytoMed Therapeutics signs Business & Research
SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) — CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical…